InsiderGauge
Checking updates…
Dashboard

Douglas Earl Martininsider trades

In SEC Form 4 filings, Douglas Earl Martin is listed as SVP, General Counsel of Allogene Therapeutics, Inc. (ALLO). In the last 90 days, Douglas Earl Martin sold $63K of Allogene Therapeutics, Inc. (ALLO) on the open market and bought none.

Companies and roles

CompanyRoleTransactionsLast filed
ALLOAllogene Therapeutics, Inc.SVP, General Counsel1Aug 25

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-25

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
ALLOAllogene Therapeutics, Inc.Aug 21Aug 25S29,697$2.12Sale −$62,958488,267NoForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.